Currently, there are 203.83M common shares owned by the public and among those 185.70M shares have been available to trade.
The company’s stock has a 5-day price change of 4.53% and -18.62% over the past three months. WEN shares are trading -8.04% year to date (YTD), with the 12-month market performance down to -22.25% lower. It has a 12-month low price of $13.72 and touched a high of $20.65 over the same period. WEN has an average intraday trading volume of 4.11 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 2.71%, -4.26%, and -12.93% respectively.
Institutional ownership of Wendy’s Co (NASDAQ: WEN) shares accounts for 84.08% of the company’s 203.83M shares outstanding.
It has a market capitalization of $3.06B and a beta (3y monthly) value of 0.74. The stock’s trailing 12-month PE ratio is 15.88, while the earnings-per-share (ttm) stands at $0.94. The company has a PEG of 2.20 and a Quick Ratio of 1.83 with the debt-to-equity ratio at 15.78. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.40% over the week and 2.85% over the month.
Analysts forecast that Wendy’s Co (WEN) will achieve an EPS of 0.2 for the current quarter, 0.28 for the next quarter and 1.13 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.17 while analysts give the company a high EPS estimate of 0.17. Comparatively, EPS for the current quarter was 0.23 a year ago. Earnings per share for the fiscal year are expected to increase by 0.54%, and 11.54% over the next financial year. EPS should shrink at an annualized rate of 7.22% over the next five years, compared to 12.95% over the past 5-year period.
Looking at the support for the WEN, a number of firms have released research notes about the stock. Morgan Stanley stated their Underweight rating for the stock in a research note on January 21, 2025, with the firm’s price target at $22-$14. Goldman coverage for the Wendy’s Co (WEN) stock in a research note released on June 13, 2024 offered a Sell rating with a price target of $16. Stephens was of a view on April 12, 2024 that the stock is Equal-Weight, while Bernstein gave the stock Mkt Perform rating on February 22, 2024, issuing a price target of $24- $20. JP Morgan on their part issued Neutral rating on February 21, 2024.
